Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial
Open Access
- 8 August 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 131 (9), 2376-2386
- https://doi.org/10.1093/brain/awn173
Abstract
Olfactory ensheathing cells show promise in preclinical animal models as a cell transplantation therapy for repair of the injured spinal cord. This is a report of a clinical trial of autologous transplantation of olfactory ensheathing cells into the spinal cord in six patients with complete, thoracic paraplegia. We previously reported on the methods of surgery and transplantation and the safety aspects of the trial 1 year after transplantation. Here we address the overall design of the trial and the safety of the procedure, assessed during a period of 3 years following the transplantation surgery. All patients were assessed at entry into the trial and regularly during the period of the trial. Clinical assessments included medical, psychosocial, radiological and neurological, as well as specialized tests of neurological and functional deficits (standard American Spinal Injury Association and Functional Independence Measure assessments). Quantitative test included neurophysiological tests of sensory and motor function below the level of injury. The trial was a Phase I/IIa design whose main aim was to test the feasibility and safety of transplantation of autologous olfactory ensheathing cells into the injured spinal cord in human paraplegia. The design included a control group who did not receive surgery, otherwise closely matched to the transplant recipient group. This group acted as a control for the assessors, who were blind to the treatment status of the patients. The control group also provided the opportunity for preliminary assessment of the efficacy of the transplantation. There were no adverse findings 3 years after autologous transplantation of olfactory ensheathing cells into spinal cords injured at least 2 years prior to transplantation. The magnetic resonance images (MRIs) at 3 years showed no change from preoperative MRIs or intervening MRIs at 1 and 2 years, with no evidence of any tumour of introduced cells and no development of post-traumatic syringomyelia or other adverse radiological findings. There were no significant functional changes in any patients and no neuropathic pain. In one transplant recipient, there was an improvement over 3 segments in light touch and pin prick sensitivity bilaterally, anteriorly and posteriorly. We conclude that transplantation of autologous olfactory ensheathing cells into the injured spinal cord is feasible and is safe up to 3 years of post-implantation, however, this conclusion should be considered preliminary because of the small number of trial patients.Keywords
This publication has 48 references indexed in Scilit:
- Morphology and Morphometry of Human Chronic Spinal Cord Injury Using Diffusion Tensor Imaging and Fuzzy LogicAnnals of Biomedical Engineering, 2007
- OEG implantation and step training enhance hindlimb-stepping ability in adult spinal transected ratsBrain, 2007
- A systematic review of functional ambulation outcome measures in spinal cord injurySpinal Cord, 2007
- A multicenter international study on the Spinal Cord Independence Measure, version III: Rasch psychometric validationSpinal Cord, 2006
- Perceptual threshold to cutaneous electrical stimulation in patients with spinal cord injurySpinal Cord, 2006
- Survival and migration of human and rat olfactory ensheathing cells in intact and injured spinal cordJournal of Neuroscience Research, 2006
- Investigating the Suitability of the Clinical Outcome Variables Scale (COVS) as a Mobility Outcome Measure in Spinal Cord Injury RehabilitationPhysiotherapy Canada, 2003
- Late recovery following spinal cord injuryJournal of Neurosurgery: Spine, 2002
- Olfactory ensheathing cells — another miracle cure for spinal cord injury?Nature Reviews Neuroscience, 2001
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969